RxDoctor Payments Data

Adam Ray, MD

Otolaryngology · Tucson, AZNPI 1154371003

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Stryker at 38.2% of the total.

$5,017in general payments, 2019–2025

Across 147 payments — averaging $34.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • AstraZeneca$797
  • Sanofi$774
  • Inspire Medical Systems, Inc.$548
  • Optinose US, Inc.$178
  • Medtronic$160
  • plus $643 from 13 others

What the payments were for

  • Food & beverage$5,017100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,017 in reported general payments places this provider in the 80th percentile of 150 otolaryngology providers in Arizona.

See all otolaryngology providers in Arizona

Medicare billing

Part B allowed, 2024
$348,245
Medicare patients
676
Services billed
8,864

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab12$44,453
Fluticasone Propionate797$22,389
Azelastine Hcl244$12,225
Ipratropium Bromide140$9,623
Fluocinolone Acetonide Oil121$6,444
Omeprazole229$3,954
Montelukast Sodium144$2,031
Methylprednisolone113$781
Ofloxacin16$604
Cephalexin50$523
Albuterol Sulfate HfaAlbuterol Sulfate14$429
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen56$391
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$190
Oxycodone Hcl32$147
Doxycycline Hyclate12$104

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →